Retinoblastoma - Pipeline Review, H1 2014 - New Study Released
This report provides comprehensive information on the therapeutic development for Retinoblastoma, complete with comparative analysis at variouss stages,
therapeutics assessment by drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players
involved in the therapeutic development for Retinoblastoma and special
features on late-stage and discontinued projects.
http://www.usprwire.com/Detailed/Health_Wellbeing/Retinoblastoma_-_Pipeline_Review_H1_2014_-_New_Study_Released_323406.shtml
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.